Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00427011 · ClinicalTrials.gov registry record · Phase 2
A Study of E2007 In Patients With Parkinson's Disease
A Phase 2 study, sponsored by Eisai.
- Terminated
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT00427011 is a Phase 2 study that was terminated before completion, run by Eisai. The registered enrollment target is 25 participants.
The verdict
NCT00427011, a Phase 2 study, was terminated before completion, sponsored by Eisai.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
Phase IIb open-label extension study for patients with Parkinson's Disease. All patients will receive active study drug. The study will involve outpatient visits only. Patients who completed Study E2007-A001-214 (Cohorts I and II) and who meet inclusion/exclusion criteria will be enrolled and enter the 12-week Titration Phase (from "Dispense Study Drug" at Week 0 \[Visit 2\] through Week 12 \[Visit 7\]) followed by the Maintenance Phase (from Week 12 \[Visit 7\] to end of study).
Interventions
- DRUG E2007
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00427011
The ClinicalTrials.gov registry entry for NCT00427011 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which E2007 is the first listed.
NCT00427011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00427011 about?
NCT00427011 is a clinical study titled "A Study of E2007 In Patients With Parkinson's Disease". Phase IIb open-label extension study for patients with Parkinson's Disease. All patients will receive active study drug. The study will involve outpatient visits only. Patients who completed Study E2007-A001-214 (Cohorts I and II) and who meet inclusion/exclusion criteria will be enrolled and enter ...
What is the current status of trial NCT00427011?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2007-02. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00427011?
The interventions under investigation include: E2007 (DRUG).
Who is sponsoring clinical trial NCT00427011?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.